Defining and managing NF1-related peripheral nerve sheath tumors at risk for malignant transformation: Consensus from the Atypical Neurofibroma Symposium.
People with neurofibromatosis type 1 (NF1) are at risk for developing peripheral nerve sheath tumors (PNSTs) ranging from benign neurofibromas to high-grade sarcomas. PNSTs known as atypical neurofibromas are at increased risk for malignant transformation. In 2017 the term ANNUBP (atypical neurofibromatous neoplasm of uncertain biologic potential) was proposed for PNSTs at increased risk for malignant transformation based on histopathologic features. Subsequently it was recognized that PNSTs not meeting ANNUBP criteria could still have concerning clinical, imaging and molecular features. A State of the Science conference addressed how to define these pre-cancerous PNSTs and reached consensus regarding clinical management and priority areas of research. Key recommendations from this symposium include: (1) using a combination of histologic, molecular and imaging features to define pre-malignant "at-risk" PNST; (2) recognizing that people with NF1 may be divided into "higher-risk" and "average-risk" for MPNST based on features such as their germline NF1 variant, internal tumor burden and history of malignancy or radiotherapy and; (3) the need to validate consensus screening and surveillance strategies based on personal and tumor-related risk factors. These recommendations will advance the ability to standardize care, and potentially fuel research that enables early diagnosis, prevention of malignant transformation and improved outcomes.
Authors
- Carol D. Morris (ORCID: https://orcid.org/0000-0002-4007-9476)
- Benjamin I. Siegel (ORCID: https://orcid.org/0000-0002-3022-6719)
- Dave Viskochil
- Laura Marie Fayad (ORCID: https://orcid.org/0000-0002-4927-4008)
- Heike Elisabeth Daldrup-Link (ORCID: https://orcid.org/0000-0002-4929-819X)
- Andrea M. Gross (ORCID: https://orcid.org/0000-0003-1646-4531)
- Ina Ly (ORCID: https://orcid.org/0000-0003-0494-2946)
- Lennart Well (ORCID: https://orcid.org/0000-0003-2491-1346)
- Bruce R. Korf (ORCID: https://orcid.org/0000-0001-8272-339X)
- Yin Wu (ORCID: https://orcid.org/0000-0002-4323-5083)
- Angela C. Hirbe (ORCID: https://orcid.org/0000-0003-1719-0771)
- Brian Weiss (ORCID: https://orcid.org/0000-0001-5154-3134)
- Shivani Ahlawat (ORCID: https://orcid.org/0000-0003-4437-5237)
- Inka Ristow (ORCID: https://orcid.org/0000-0002-3032-2321)
- Miriam A. Bredella (ORCID: https://orcid.org/0000-0001-5482-0440)
- K. Elizabeth Hawk (ORCID: https://orcid.org/0000-0001-5738-2044)
- Rosalie E. Ferner (ORCID: https://orcid.org/0000-0002-9169-4698)
- Jaishri O'Neill Blakeley (ORCID: https://orcid.org/0000-0002-1049-0993)
- Eva Dombi (ORCID: https://orcid.org/0000-0002-5323-6995)
- Kimberly K. Amrami (ORCID: https://orcid.org/0000-0003-1539-6813)
- Brigitte C. Widemann (ORCID: https://orcid.org/0000-0002-9198-7175)
- Carlos Guillermo Romo (ORCID: https://orcid.org/0000-0002-0260-7047)
- Allan Joel Belzberg (ORCID: https://orcid.org/0000-0003-1158-2117)
- Christine A. Pratilas (ORCID: https://orcid.org/0000-0002-7116-0605)
- Fabian Mc. Johnston (ORCID: https://orcid.org/0000-0002-2794-7179)
- Mark D. Murphey (ORCID: https://orcid.org/0000-0002-6085-5751)
- Adam S. Levin (ORCID: https://orcid.org/0000-0003-0450-7821)
- Prashant Chittiboina (ORCID: https://orcid.org/0000-0001-9349-4756)
- Marcus Ratley
- Michael J. Fisher (ORCID: https://orcid.org/0000-0003-3753-3700)
- Steven Sheard
- AeRang Kim
Institutions
- Cincinnati Children's Hospital Medical Center (US)
- Guy's Hospital (GB)
- National Institutes of Health (US)
- Mayo Clinic (US)
- Memorial Sloan Kettering Cancer Center (US)
- Children's Hospital of Philadelphia (US)
- Children's National (US)
- Johns Hopkins University (US)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- Washington University in St. Louis (US)
- University of Utah (US)
- Johns Hopkins Medicine (US)
- Riley Hospital for Children (US)
- University of Alabama at Birmingham (US)
- NYU Langone Health (US)
- Massachusetts General Hospital (US)
- Center for Neuro-Oncology (US)
- University Medical Center Hamburg-Eppendorf (DE)
- National Institute of Neurological Disorders and Stroke (US)
- Stanford Medicine (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- Johns Hopkins Hospital (US)
- Indiana University School of Medicine (US)
- Wake Forest University Health Sciences (US)
- Wake Forest University (US)
- New York University (US)
- University of Cincinnati (US)
- University of Pennsylvania (US)
- Stanford University (US)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-13
- DOI
- https://doi.org/10.1093/neuonc/noag275
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 0.00